Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Alison Grann"'
Autor:
Praveen Pendyala, MD, Alexander G. Goglia, PhD, Malcolm D. Mattes, MD, Alison Grann, MD, David Huang, MD, Raquel T. Wagman, MD, Zeinab Abou Yehia, MD, Jennifer Yoon, MD, Ronald D. Ennis, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100680- (2021)
Purpose: This study aimed to define how the coronavirus disease of 2019 (COVID-19) pandemic affected the role, timing, and delivery of radiation therapy (RT) in a high-prevalence region at the height of the initial U.S. outbreak. Methods and Material
Externí odkaz:
https://doaj.org/article/a0a6b6d1976043c08a5e3c4ec2f54b2d
Autor:
Lara Hathout, MD, Ronald D. Ennis, MD, Malcolm D. Mattes, MD, Raquel T. Wagman, MD, Alison Grann, MD, Salma K. Jabbour, MD, Rachana Singh, MD, Ning J. Yue, PhD, Bruce G. Haffty, MD, Irina Vergalasova, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100600- (2021)
Purpose: This study aimed to evaluate whether the coronavirus disease of 2019 (COVID-19) pandemic resulted in treatment delays in patients scheduled for or undergoing brachytherapy. Methods and Materials: A retrospective cohort study was conducted ac
Externí odkaz:
https://doaj.org/article/512b21e98efd42e4b61d4492c26a28eb
Autor:
Matthew P. Deek, David A. August, Lara Hathout, Alison Grann, Sinae Kim, Yin Zhang, Timothy J. Kennedy, Nrusingh C. Biswal, Andrew Zhang, Mutlay Sayan, John Langenfeld, Salma K. Jabbour, Raquel T. Wagman, Usha Malhotra
Publikováno v:
Journal of Gastrointestinal Oncology. 10:513-522
Background: Hematologic toxicity (HT) commonly occurs during chemoradiation therapy (CRT) for esophageal cancer. We sought to determine radiation doses that correlate with declines in blood counts due to vertebral body (VB) irradiation during CRT. Me
Autor:
Jennifer Yoon, Raquel Wagman, David Huang, Alexander G. Goglia, Ronald D. Ennis, Alison Grann, Praveen Pendyala, Malcolm D. Mattes, Zeinab Abou Yehia
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100680-(2021)
Advances in Radiation Oncology
Advances in Radiation Oncology
This study, set at the epicenter of the initial U.S. COVID-19 outbreak, shows that nearly 1/5 of cancer patients seeking radiotherapy during the initial surge experienced a COVID-related care change. Notably, advanced age, curative intent, and rectal
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics
International Journal of Radiation Oncology, Biology, Physics
International Journal of Radiation Oncology, Biology, Physics
Autor:
Malcolm D. Mattes, Rachana Singh, Raquel T. Wagman, Salma K. Jabbour, Ronald D. Ennis, Lara Hathout, Ning J. Yue, Alison Grann, Irina Vergalasova, Bruce G. Haffty
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100600-(2021)
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100600-(2021)
Purpose /Objectives: To evaluate whether the COVID-19 pandemic resulted in treatment delays in patients scheduled for or undergoing brachytherapy. Materials/Methods A retrospective cohort study was conducted across four affiliated sites following loc
Autor:
Bruce G. Haffty, Alison Grann
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:473
Autor:
Russell McBride, Jian Wang, Judith S. Jacobson, Victor R. Grann, Alison Grann, Dawn L. Hershman, Alfred I. Neugut, John J. Doyle
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 68:82-93
Purpose The benefits of adjuvant radiation therapy (RT) for breast cancer may be counterbalanced by the risk of cardiac toxicity. We studied the cardiac effects of RT and the impact of pre-existing cardiac risk factors (CRFs) in a population-based sa
Autor:
Usha Malhotra, Elizabeth Poplin, Alison Grann, Salma K. Jabbour, Matthew P. Deek, David A. August, R.T. Wagman, Sinae Kim, A. Zhang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 99:E205
Autor:
Raquel Wagman, Alison Grann
Publikováno v:
Surgical Clinics of North America. 81:667-681
According to data from the American Cancer Society, pancreatic carcinoma will affect 28,300 people in the year 2000; 28,200 will die from the disease. Pancreatic carcinoma is the fourth leading cause of mortality from malignant disease in the United